AlloVir Inc (ALVR)
0.763
+0.01
(+1.71%)
USD |
NASDAQ |
Apr 22, 16:00
0.7638
0.00 (0.00%)
Pre-Market: 20:00
AlloVir Free Cash Flow (Quarterly): -30.74M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -30.74M |
| September 30, 2023 | -34.48M |
| June 30, 2023 | -27.12M |
| March 31, 2023 | -32.12M |
| December 31, 2022 | -31.57M |
| September 30, 2022 | -35.13M |
| June 30, 2022 | -28.88M |
| March 31, 2022 | -46.48M |
| December 31, 2021 | -27.70M |
| September 30, 2021 | -36.47M |
| Date | Value |
|---|---|
| June 30, 2021 | -23.18M |
| March 31, 2021 | -19.00M |
| December 31, 2020 | -21.09M |
| September 30, 2020 | -18.06M |
| June 30, 2020 | -11.12M |
| March 31, 2020 | -10.54M |
| December 31, 2019 | -8.989M |
| September 30, 2019 | -6.396M |
| June 30, 2019 | -3.132M |
| March 31, 2019 | -1.977M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-46.48M
Minimum
Mar 2022
-3.132M
Maximum
Jun 2019
-23.80M
Average
-27.12M
Median
Jun 2023
Free Cash Flow (Quarterly) Benchmarks
| Arcutis Biotherapeutics Inc | -56.25M |
| CEL-SCI Corp | -4.953M |
| AIM ImmunoTech Inc | -9.956M |
| IGC Pharma Inc | -1.674M |
| NovaBay Pharmaceuticals Inc | -0.316M |